Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1998-1-29
pubmed:databankReference
pubmed:abstractText
Various histological subtypes of leukaemia and lymphoma are associated with diagnostic chromosome translocations, and substantial strides have been made in determining the specific oncogenes targetted by those translocations. We report the cloning of a novel fusion oncogene associated with a unique leukaemia/lymphoma syndrome. Patients afflicted with this syndrome present with lymphoblastic lymphoma and a myeloproliferative disorder, often accompanied by pronounced peripheral eosinophilia and/or prominent eosinophilic infiltrates in the affected bone marrow, which generally progress to full-blown acute myelogenous leukaemia within a year of diagnosis. A specific chromosome translocation, t(8;13)(p11;q11-12), is found in both lymphoma and myeloid leukaemia cells from these patients, supporting bi-lineage differentiation from a transformed stem cell. We find that the 8p11 translocation breakpoints, in each of four patients, interrupt intron 8 of the fibroblast growth factor receptor 1 gene (FGFR1). These translocations are associated with aberrant transcripts in which four predicted zinc-finger domains, contributed by a novel and widely expressed chromosome-13 gene (ZNF198), are fused to the FGFR1 tyrosine-kinase domain. Transient expression studies show that the ZNF198-FGFR1 fusion transcript directs the synthesis of an approximately 87-kD polypeptide, localizing predominantly to the cytoplasm. Our studies demonstrate an FGFR1 oncogenic role and suggest a tumorigenic mechanism in which ZNF198-FGFR1 activation results from ZNF198 zinc-finger-mediated homodimerization.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1061-4036
pubmed:author
pubmed:issnType
Print
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
84-7
pubmed:dateRevised
2010-5-26
pubmed:meshHeading
pubmed-meshheading:9425908-Amino Acid Sequence, pubmed-meshheading:9425908-Animals, pubmed-meshheading:9425908-Base Sequence, pubmed-meshheading:9425908-Carrier Proteins, pubmed-meshheading:9425908-Cell Transformation, Neoplastic, pubmed-meshheading:9425908-Chromosomes, Human, Pair 13, pubmed-meshheading:9425908-Chromosomes, Human, Pair 8, pubmed-meshheading:9425908-DNA-Binding Proteins, pubmed-meshheading:9425908-Humans, pubmed-meshheading:9425908-Mice, pubmed-meshheading:9425908-Molecular Sequence Data, pubmed-meshheading:9425908-Myeloproliferative Disorders, pubmed-meshheading:9425908-Oncogene Proteins, Fusion, pubmed-meshheading:9425908-Precursor Cell Lymphoblastic Leukemia-Lymphoma, pubmed-meshheading:9425908-Receptor, Fibroblast Growth Factor, Type 1, pubmed-meshheading:9425908-Receptor Protein-Tyrosine Kinases, pubmed-meshheading:9425908-Receptors, Fibroblast Growth Factor, pubmed-meshheading:9425908-Syndrome, pubmed-meshheading:9425908-Transcription Factors, pubmed-meshheading:9425908-Translocation, Genetic, pubmed-meshheading:9425908-Zinc Fingers
pubmed:year
1998
pubmed:articleTitle
FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome.
pubmed:affiliation
Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't